9 achievements

Bush, Jason A.

College of Science and Mathematics » Department of Biology
Amirikia, K., Mills, P., Bush, J., & Newman, L.  (2011). Higher population-based incidence rates of triple-negative breast cancer among young African-American women.  Cancer. 117(12), 2747-2753.
Find It!
Bush, J., Kitaura, H., Ma, Y., Teitelbaum, S., Ross, F., & Smith, J.  (2012). Comparative proteomic analysis of a cytosolic fraction from b3 integrin-deficient cells.  Cancer Genomics & Proteomics. 9(1), 1-13.
Find It!
Carillo, B., Villalvazo, A., Nitido, A., Ritchey, J., & Bush, J.  (2009). Multi-drug resistant ovarian cancer cells are less susceptible to orlistat-induced cell death. Presented at 2nd Cancer Health Disparities–Minorities in Cancer Research, Carefree, AZ.
Chu, R., Miller, S., & Bush, J.  (2009). Secretome Analyses from Staged Pancreatic Cancer Cell Lines. Presented at 5th US Human Proteome Organization (USHUPO), San Diego, CA.
Hale, J., Yamamoto, F., & Bush, J.  (2010). Proteomic evaluation of pesticide-resistant breast cancer cell lines. Presented at Experimental Biology Meeting, Anaheim, CA.
Morshedian, S., Contreras, C., Hamud, W., Dhakal, B., Khanal, B., & Bush, J.  (2011). Anti-angiogenic effects of zoledronic acid on osteotropic breast cancer cells. Presented at Experimental Biology Meeting, Washington, DC.
Morshedian, S., Contreras, C., & Bush, J.  (2010). Zoledronic acid (Zometa®) preferentially induces cell death in a bone-metastasizing breast cancer cell line. Presented at Special Conference of the American Association of Cancer Research, San Diego, CA.
Morshedian, S., Contreras, C., & Bush, J.  (2010). Zoledronic acid increases anti-angiogenic factors in an osteotropic breast cancer cell line. Presented at Experimental Biology Meeting, Anaheim, CA.
Piestrup, N., Liu, J., & Bush, J.  (2010). Development of Protocols for Enrichment of Specific Endocytic Vesicles Involved in β3 Integrin Recycling in a Cell Culture Model. Presented at 31st Annual Central California Research Symposium.